Skip to main content
Fig. 4 | BMC Gastroenterology

Fig. 4

From: Serum O-glycosylated hepatitis B surface antigen levels in patients with chronic hepatitis B during nucleos(t)ide analog therapy

Fig. 4

Relationships between O-glycosylated HBsAg levels and conventional HBV marker levels after 48 weeks of NA therapy. Data were analyzed using Spearman’s rank correlation coefficient. Light gray circles represent HBeAg-negative patients, dark gray circles represent HBeAg-positive patients. HBcrAg hepatitis B core-related antigen, HBeAg hepatitis B e antigen, HBsAg hepatitis B surface antigen, HBV hepatitis B virus, NA nucleos(t)ide analog

Back to article page